Canada markets open in 1 hour 17 minutes

The Cooper Companies, Inc. (COO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
333.76-6.49 (-1.91%)
At close: 04:03PM EDT
333.76 0.00 (0.00%)
After hours: 04:34PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close340.25
Open335.65
Bid0.00 x 800
Ask535.00 x 1100
Day's Range332.92 - 338.80
52 Week Range309.43 - 463.59
Volume503,318
Avg. Volume320,913
Market Cap16.455B
Beta (5Y Monthly)0.85
PE Ratio (TTM)17.72
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.06 (0.02%)
Ex-Dividend DateJan 20, 2022
1y Target EstN/A
  • News Direct

    CooperCompanies Releases 2021 Environmental, Social, and Governance Highlights Report; Signs on to United Nations Global Compact

    CooperCompanies has published its 2021 Environmental, Social, and Governance (ESG) Highlights Report, sharing the Company’s progress on ESG items most important to its businesses and stakeholders, ...

  • GlobeNewswire

    CooperCompanies to Participate in the Jefferies Healthcare Conference

    SAN RAMON, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 9, 2022. Al White, President and CEO, will represent the Company in a session scheduled to begin at 1:00 PM ET. This webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A webcast replay will be available approximately 48 hours after the live webcast. Ab

  • GlobeNewswire

    Aspira Women’s Health Reports First Quarter 2022 Financial Results

    Product Revenue Increased 30% to $1.8 million; OVA1plus Volume Grew 28% to 4,819 Units New Ordering Physicians in the First Quarter Grew 47% to 603 Year Over Year Board and Leadership appointments announced Conference Call and Webcast scheduled for today, May 11th at 8:30 a.m. ET AUSTIN, Texas, May 11, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for